The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial

EuroIntervention 2018;14:e418-e425 published online ahead of print May 2018 published online e-edition July 2018. DOI: 10.4244/EIJ-D-18-00293

1. ELSAN, Pôle Santé République Centre de Cardiologie Interventionnelle, Clermont-Ferrand, France; 2. Hôpital Privé Dijon-Bourgogne, Dijon, France; 3. Ramsay Générale de Santé, ICPS, Massy, France; 4. CHUV, Lausanne, Switzerland; 5. Belfast Health & S

Aims: The LEADERS FREE trial has demonstrated that a polymer-free Biolimus A9-coated stent (BA9-DCS) is superior to a bare metal stent (BMS) for high bleeding risk (HBR) patients when tre

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Complete two-year follow-up with formal non-inferiority testing on primary outcomes of the AIDA trial comparing the Absorb bioresorbable scaffold with the XIENCE drug-eluting metallic stent in routine PCI